Basal Cell Carcinoma is the most common human malignant neoplasm. Vulvar basal cell carcinoma is rare, accounting for less than 5% of all vulvar neoplasms. Vulvar basal cell carcinomas are usually diagnosed late because they are often asymptomatic and tend to grow at slow rates. They are usually diagnosed late because they are often asymptomatic. However, these tumours may appear in areas which are normally covered with ultraviolet light.
Introduction
Basal-cell carcinoma (BCC) is one of the most common types of cancers found. Incidence increases with age but the development is conditioned by the duration of lifetime exposure to ultraviolet radiation, so 85% of these are found in areas exposed to the sun such as head or neck but they can be found in rare situations in less exposed areas where the lesions and hard to identify.
These rare locations are: perianal locations, axilla or vulva (1) . Since its first description by Temesvary in 1926, 200 cases of vulvar BCC have been listed in the literature. BCC vulvar accumulates below 1% of all BCCs and less than 5% of all vulvar cancers, and it is more common in menopausal women (2, 3) .
Clinically vulvar BCC is a tumour with indolent and destructive local development, which can rarely metastasize, but the rate of local recurrence can reach 20% (4, 5) .
Case report
We present the case of 60-year-old woman who 
Discussion
The most important risk factor for the increased incidence of BCC is directly related to intense exposure to ultraviolet radiation (6) . The reasons why this disease appears in areas which are not exposed to sunlight is still debated. Various factors have been incriminated such as: chronic vulvar irritation (e.g. long-term use of diapers), ionizing radiation, arsenic, chronic inflammation, hamartomas, immune deficiency and genetic alterations: Activation of the hedgehog signaling pathway leading to overexpression of GLI1 or GLI2 gene production, loss of function mutations of PTCH1 or PTCH2, activating mutations of SMO, also p53 mutations have been identified in many cases (5) .
The disease usually affects older women with ages varying from 34 years to 96 years but with an average of 70 years (5) . Due to its hidden location, diagnosis is usually late; symptoms are non-specific while patients tend to be older in age and don't observe the disease's Mohs micrographic surgery should to be taken into account to ensure the best results for the patient (9, 10) .
Metastasis is rarely encountered, in under 0.1% of cases and is usually distributed to the inguinal lymph nodes but tumoral cells can be found in other sites such as skin, bone or lung. The systemic disease is favored by a large tumour, usually above 2cm (11, 12) .
Postoperative radiotherapy is an option in selected cases. Local wide excision remains the mainstay primary treatment even for recurrence (13) .
In our case, the hypothesis of chemotherapy induced non-melanoma skin cancer rose. However, in a case-control clinical trial by Rubino et al., no association was found between chemotherapy and non-melanoma skin cancer (14) . The possibility that adjuvant chemotherapy influenced the aetiology of the skin cancer, in this case, is therefore low.
Conclusions
In conclusion, early detection of BCC's is critical to allow complete surgical cure so any abnormality on the vulva should be biopsied. A wide safety margin of 1cm should be achieved when resecting the tumour and the physician should keep in mind that the BCC's of the vulva has a high recurrence rate. Previous chemotherapy is not associated with this type of non-melanoma skin cancer.
